HCA Healthcare Inc (HCA) Q3 2026 (USD): adj. EPS 7.22 (exp. 6.65), Revenue 19.8bln (exp. 19.33bln). Current FY adj. EBITDA 15.4-16.1bln (exp. 15.7bln)

HCA Healthcare Inc (HCA) Q3 2026 (USD): adj. EPS 7.22 (exp. 6.65), Revenue 19.8bln (exp. 19.33bln). Current FY adj. EBITDA 15.4-16.1bln (exp. 15.7bln)

A top-and-bottom-line beat with full-year EBITDA guidance straddling consensus is the standard shape of a well-received for-profit hospital print, and the historical pattern with this peer set is that the guidance treatment matters as much as the quarter itself: raising after a beat tends to extend the move, while a merely reaffirmed range after a strong quarter has often been read as conservative and faded. The drivers that have mattered in prior cycles for this group are admission and acuity trends, contract labor costs as a share of revenue, and payer mix, with supplemental Medicaid payments and policy swings periodically distorting comparability. HCA has traditionally been the bellwether of the listed hospital operators, so the read-across to the rest of the for-profit chain and, to a lesser degree, managed care names on utilization has been the established follow-on pattern. The conference call is where these prints are usually re-priced, with volume guidance and labor commentary the tells rather than the headline EPS. The revenue beat alongside the EPS beat points to volume or pricing rather than pure cost control, which is the combination the group has historically been rewarded for. Confidence in the classification is high; the note is qualitative because only the headline figures are known.